The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Clinical Roundup

VCU Massey study: Protein-based combination therapy overcomes tumor resistance to colorectal cancer treatment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Researchers at VCU Massey Cancer Center identified a novel, protein-based combination therapy through which tumor resistance can be overcome to more effectively treat colorectal cancer. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Trials & Tribulations

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

March is National Colorectal Cancer Awareness Month. It is a reminder of a heartbreaking trend that oncologists like me are witnessing in our clinics: Last year, for the first time, colorectal cancer became the leading cause of cancer-related death in Americans under the age of 50, according to data published earlier this year in JAMA.
By Richard M. Goldberg
Clinical Roundup

VCU Massey researchers lead international effort to produce multi-omic digital atlas of oral tissues

Researchers at VCU Massey Comprehensive Cancer Center led an international effort to create a multi-omic atlas of oral tissues with the aim of advancing the understanding of the immunoregulatory nature of human oral tissues. Recent analyses using data from this atlas suggest that fibroblasts may serve as the core regulators of structural immunity in the mouth.
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account